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Multiple sclerosis (MS; also known as disseminated sclerosis 
or encephalomyelitis disseminated) was described by Charcot and 
Vulpain in 1866 for the first time.[1] MS is a chronic, disabling, 
incurable recurrent demyelination of the central nervous sys‑
tem (CNS) by which about 2.5 million people in the world have 
been affected.[2‑4]
MS is an inflammatory disease of the CNS. The inflamma‑
tion causes damage and forms plaques or lesions that are located 
primarily in the CNS white matter. At the site of the inflammatory 
lesions, the myelin sheath is destroyed in the process of demy‑
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Multiple sclerosis (MS) is a chronic, disabling, recurrent demyelination of the central nervous system (CNS). It could affect different 
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elination. When myelin is lost, transmission of signals through 
nerves is slowed down or blocked. In some cases, the myelin 
sheaths around axons can be rebuilt on reducing inflammation. This 
process is called remyelination and is performed by oligodendro‑
cytes. If there are not enough oligodendrocytes at the lesion site, 
remyelination will not occur or will be done partially. Therefore, 
nerves will carry out their functions in an abnormal pathway, and 
the axons continue to remain for long periods without damage. The 
lost myelin sheath can be replaced by scar tissue where it is called 
MS; multiple means many and sclerosis means scar formation.[1]
When the axons are damaged, they do not completely lose 
their function. As the disease progresses, oligodendrocytes and, 
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ultimately, axons are destroyed, leading to a worsening of the 
symptoms. There is strong evidence that the destruction is caused 
by the immune system, which indicates that MS is an autoimmune 
disease.[1]
Prevalence of MS
The prevalence of MS in the Northern Hemisphere is more 
than in the Southern Hemisphere.[3] Probably more than 2 million 
people in the world have been affected with MS, and mainly they 
experience the first symptoms between the ages of 20 and 40 years. 
Women are two times more likely to develop the disease.[5] Iran 
is located in a low‑risk area for MS[6] and prevalence of MS in 
different regions of Iran varies from 5.3 to 74.28 per 100,000.[7]
Pathology
MS affects neurons, the cells of the brain and spinal cord that 
carry information, create thoughts and perception, and allow the 
brain to control the body. Around these neurons is a fatty acid 
layer that is known as the myelin sheath. Myelin sheath helps 
the neurons to transfer signals. MS causes gradual destruction of 
myelin and transection of axon in the brain and spinal cord. Ac‑
cording to the area of demyelination in the brain and spinal cord, 
MS manifests its symptoms.[3,8]
Pathologically, MS is detected by appearance of demyelinated 
areas and perivascular T cell inflammation in the white matter of 
CNS. However, some axons may be not affected by this patho‑
logical process.[3,8]
Severity of demyelination is determined by the preservation 
or destruction of oligodendrocytes. It is indicated that in the early 
stage of disease, more oligodendrocytes are preserved in plaque 
lesion. Thus, some degree of remyelination is still possible. In other 
patients in whom oligodendrocytes are destroyed completely, the 
possibility of remyelination is very low.[3,8]
Causes
Today, the prevailing theory is that MS is caused by the im‑
mune system attacking the nervous system and, thus, is commonly 
known as an autoimmune disease.[3,9] There is also a more trivial 
theory which says that MS is not an autoimmune disease but is a 
metabolic neurodegenerative disorder. However, the main cause 
of MS is still unknown.[3,10]
Although the exact mechanism of the disease is unknown, 
there is considerable evidence toward the autoimmune nature of 
the disease. It has been observed that the levels of immunoglobulin 
G (IgG) in the cerebrospinal fluid of MS patients are increased, as 
it is thought that IgG is produced in the CNS. With immunofluo‑
rescent and immunoperoxidase techniques, IgG has been detected 
in the white matter of normal‑appearing brain as well as in MS 
plaque tissue. According to the features previously observed, 
autoimmune IgG extracted from the brains of MS patients has 
anti-myelin basic protein (anti-MBP) activity.[4]
In MS, immune dysfunction can be detected locally in the CNS 
and cerebrospinal fluid, as well as systemically in peripheral cir‑
culation. Autoimmune nature of MS has long been suspected. It is 
known that patients with MS have inflammation and demyelination 
in their CNS and oligoclonal bands in their cerebrospinal fluid.[3]
MS symptoms
Mainly, every function that is completely or partially controlled 
by the CNS could be lost. According to the CNS domains which 
may be affected and how badly is the are damaged, the type and 
severity of symptoms widely vary.[1]
Relapse‑remitting MS (RRMS) type mainly starts with sen‑
sory disturbance, unilateral optic neuritis, diplopia (internuclear 
ophthalmoplegia), Lhermitte’s signs (limbs and trunk paresthesia 
associated with the curvature of the neck), limb weakness, clumsi‑
ness, gait ataxia, and neurological bladder and bowel dysfunction. 
Many patients suffer from fatigue that worsens in the afternoon and 
is associated with increased physiological body temperature. Some 
patients have recurrent stereotypical phenomena (sudden pain or 
paresthesia, trigeminal neuralgia, episodic clumsiness or dysarthria, 
and tonic limb posturing), which is very common in MS.[1] Cogni‑
tive impairment in MS patients leads them to spend more time for 
their tasks.[11]
Types of MS
Three types of MS have been identified:
• RRMS
• Primary progressive multiple sclerosis (PPMS)
• Secondary progressive multiple sclerosis (SPMS).
MS patients may experience new symptoms in each relapse 
or slowly over the time. Clinically, most patients with MS suffer 
from relapsing–remitting type of the disease, which depends on 
the final phase of the disease. Following this, the most common 
type of the disease is its neurodegenerative phase called SPMS. 
Currently there is no cure for MS. Various treatments can slow 
the appearance of new symptoms, although they have their own 
side effects.[3]
Treatment of MS
Currently, there is no cure for MS. However, treatments for 
slowing the disease process or for the MS symptoms are available. 
Medications to modify the disease process constitute disease‑mod‑
ifying therapy. Four classes of drugs have been approved for the 
remission phase of MS: (1) interferon-β, (2) glatiramer acetate, (3) 
mitoxantrone (a chemotherapy agent), and (4) fingolimod.[1,12,13] 
Interferon beta-1b (Betaseron®) and interferon beta-1a (Avonex®) 
successfully reduce the number and severity of the disease relapses. 
Glatiramer acetate is an alternative drug for interferon-β in RRMS.[3]
For relapse phase of MS, corticosteroids are the choice treat‑
ment for exacerbations.
COMPLEMENTARY AND ALTERNATIVE 
MEDICINE
According to the National Institute of Health (NIH), alternative 
therapies are classified into five categories:[14,15]
• Biologically based therapies
• Alternative medical system
• Mind–body intervention
• Manipulative and body-based methods
• Energy therapies.
Namjooyan, et al. / Journal of Traditional and Complementary Medicine 4 (2014) 145‑152
147
Complementary and alternative medicine (CAM) therapies 
have been suggested for MS symptoms [Figure 1] however studies 
on their efficacy and safety are very limited. A study in California 
and Massachusetts shows that 60% of MS patients use CAM for 
treatment, and each individual uses two or three different forms 
of CAM. Another study in British Columbia has shown that 67% 
of MS patients use CAM.[15]
Biologically based therapies
Biologically based therapy includes herbs, diet, and bee venom 
therapies.[14,15]
Herbs
Herbs can be classified as herbal medicine, food, and spices. 
Herbs that are commonly used in MS are listed in Table 1.[15‑37]
Other herbs
Potentially useful
•  Herbs that are rich in γ-linoleic acid, such as flax seed and rape‑
seed, also could be useful in MS treatment due to their interven‑
tion in fatty acid metabolism and lymphocyte functions[38‑40]
•  Herbs, fruits, and berries that are rich in flavonoids, such as 
blueberry, could be helpful.[3]
Potentially harmful
•  Some plants such as Echinacea, Astragalus (黃耆 Huáng Qí), 
and Spirulina should be avoided in progressive systemic im‑
mune diseases such as MS because of their immune‑stimulating 
properties[19,41‑43]
•  Since fatigue is one of the most common symptoms in MS, 
MS patients prefer to use herbal energy enhancers. How‑
ever, it should be considered that some plants such as tea, 
coffee, and guarana which contain caffeine and cola, Citrus 
aurantium, and Ephedra (麻黃Má Huáng) could be harmful for 
MS patients and might worsen the symptoms because of their 
CNS stimulating properties.[19,44,45]
Diet and nutritional supplements
Vitamins and minerals: The advantages of vitamins and miner‑
als as supplements are not clearly understood.[15]
Antioxidant vitamins: Antioxidant vitamins, including vita‑
mins A, C, and E, seem to be useful in MS because of their ability 
to fight against free radicals, thus proving to be useful in preventing 
myelin injury and damage.[15]
Non‑vitamin antioxidant supplements such as α‑lipoic acid, 
Coenzyme Q10 (Co Q10), grape seed extract, oligomeric proan‑
thocyanidine (OPC), and pycnogenol are more expensive than 
vitamins, and their efficacy in MS patients and safety are not 
known.[15]
Vitamin D and calcium: MS prevalence is very high in areas 
with low vitamin D intake.[46] Vitamin D deficiency is associ‑
ated with increased progression of MS.[47] Vitamin D level in the 
body is influenced by two factors: Vitamin D intake through food 
sources such as milk, eggs, fish, and vegetables and the amount 
of sun exposure because cholesterol, which is made in the skin, 
is converted into cholecalciferol or D3, the active form of vitamin 
D, by UV B irradiation. Vitamin D resulting from each route will 
Figure 1. schematic explain of MS symptoms and related Complimentary and alternative therapy
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be transported to the liver to be hydroxylated.[46] In cytoplasm, 
calcitriol links to intracellular receptors and then passes through the 
nuclear membrane. The hormone–receptor complex binds to DNA 
and regulates the expression of several genes including interleu‑
kin (IL) 1, IL2, and tumor necrosis factor-alpha (TNF-α), which 
reduces inflammatory reactions. Therefore, D3 is known to be an 
immune regulator and an anti-inflammatory agent. Some studies 
show that administration of vitamin D3 in experimental allergic 
encephalomyelitis (EAE) mice and rat model may modulate the 
severity of disease. It could also reduce the complications as‑
sociated with the disease, including muscle weakness and bone 
fragility.[15,46,48]
Vitamin B12: Vitamin B12 deficiency may cause damage to the 
spinal cord and optic nerve. MS patients with B12 deficiency may 
benefit from its supplements.
Antioxidants and polyunsaturated fatty acids: Inflammatory 
conditions and lack of antioxidant defense mechanisms increase 
the reactive oxygen spies (ROS), which can damage lipids, pro‑
teins, and nucleic acids. This damage leads to mitochondrial dys‑
functions and induces cell death. Low levels of antioxidants, such 
as tocopherol, carotene, retinol, and ascorbic acid, and inhibition of 
antioxidant enzymes in a patient with MS causes oxidative stress 
leading to cell damage or death. Supplementation of antioxidants 
may be useful in MS.[49]
Risk of developing MS increases with high levels of saturated 
fatty acids in the diet. Many studies report omega-3 fatty acids as 
immune system regulators which act by reducing the levels of in‑
flammatory cytokines such as TNF-α, IL-1, IL-2, and vascular cell 
adhesion molecule (VCAM1). The beneficial effects of omega-3 
fatty acids in inflammatory diseases such as rheumatoid arthritis 
and MS have been observed. A study reported that administra‑
tion of omega‑3 fatty acids for 3 months could reduce the level 
of inflammatory cytokine. In addition, omega-3 fatty acids may 
reduce the level of matrix metalloproteinase (MMP). MMP is 
zinc-dependent endopeptidase that plays an important role in the 
migration of inflammatory cells in the CNS fluid, which breaks 
down blood–brain barriers. Studies show that MS patients have 
higher level of MMP compared with normal individuals. Chemical 
compounds of yarrow extract have beneficial effects in preventing 
or treating neurodegenerative disease.[50]
Linoleic acid: Studies on the relationship between MS preva‑
lence and dietary fatty acids have shown the effectiveness of 
linoleic acid in MS. It is suggested that linoleic acid has a role in 
regulation of cell-mediated immunity. Prostaglandin derivatives of 
linoleic acid show immunosuppressive effect.[51] Eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA) are effective in alle‑
viating the symptoms of MS patients. EPA and DHA are α‑linoleic 
acid derivatives, and they are found in fish oil.[52]
Flavonoids: Flavonoids are colored antioxidants that are 
found in plants. These substances are responsible for the color 
of fruits and vegetables. Epidemiological studies show that fruits 
and vegetables rich in flavonoids can be used for their anti-viral, 
anti-allergic, anti-inflammatory, and anti-tumor properties.[51]
Luteolin, a regulator of the immune system, can be effective in 
neurodegenerative diseases like MS by inhibiting the inflammatory 
responses. It is found in leaves of artichoke (朝鮮薊 Cháo Xiān Jì), 
rosemary (迷迭香Mí Dié Xiāng), thyme (百里香 Bǎi Lǐ Xiāng), 
and chamomile (洋甘菊 Yáng Gān Jú).[51]
Quercetin is another flavonoid which exists in onion, apple, 
and Gingko biloba.[51]
Table 1. Proved effects of medicinal herbs in EAE model and MS symptoms
Type Common name Scientific name Ingredient Effect in MS
Herbal medicine St John’s wort Hypericum 
perforatum
Hypericin Anti-depression activity[15]
Valerian (纈草 Xié Cǎo) Valeriana 
officinalis
Not defined Sedation through GABA-ergic system, increase fatigue[15]
Ginkgo (銀杏 Yín Xìng) Ginkgo biloba Ginkgolides Decrease the exacerbation in MS patients[15]
Evening primrose oil 
(月見草 Yuè Jiàn Cǎo  Yóu)
Oenothera biennis γ-linoleic acid Intervention in fatty acid metabolism and lymphocyte 
functions; could be useful in MS treatment[19,26,29,35]
Ginseng (人參 Rén Shēn) Panax ginseng Ginsenosoides Effective in increasing body resistance to stress, trauma, 
and fatigue by modulating immune function; improves 
memory, learning performance, and motor activity; 
protects against the neurodegenerative process[24]
Sage Salvia officinalis Not defined Improves cognitive function, modulates mood, enhances 
the memory of young people[24]
Marijuana (大麻 Dà Má) Cannabis spp. Cannabinoides Improves some MS-related symptoms including spasticity, 
pain, tremor, and depression; improves tremor[15]
Spices Turmeric (薑黃Jiāng Huáng) Curcuma longa Curcumin Suppresses exacerbation in neurodegenerative disease[24]






(番紅花 Fān Hóng Huā)
Crocus sativus Not defined Reduces clinical symptoms in the EAE mice model, 
delayed onset of disease, anti‑depression[16,17,21]
Black seed Nigella sativa Thymoquinone Inhibits oxidative stress, leading leading to improved 
EAE, effective in MS-associated muscle spasticity[20,30,33]
Herbal food Cranberry Vaccinium spp. Not defined Treats urine infections and inhibits some bacteria in MS 
patients[23,34]
EAE: Experimental Autoimmune Encephalomyelitis, MS: Multiple sclerosis
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Special diet: Low‑fat diet (intake of saturated fat less than 
20 g/day, avoiding whole milk, cheese, margarine, and other sources 
of hydrogenated oil, encouraging eating fish three or more times 
per week and vegetables with high polyunsaturated fat content, 
using cod‑liver oil supplement 5 g/day) could reduce the severity 
of disease and the frequency of an exacerbation episodes of MS. 
Mortality rate and serious disability in MS patients who ate saturated 
fat more than 20 g/day were more than in those on low-fat diet.[19,53]
Venom therapy
Venom therapy involves the use of bee’s venom, snake venom, 
and sea anemone venom.
Bee’s venom: Although Apis mellifera or bee’s sting can 
cause pain, its venom containing peptide, enzyme, and amines[54] 
can inhibit migration of leukocytes and decrease the amount of 
TNF-α leading to anti-inflammatory effects.[54,55] Melittin, one 
of its components, known as anti-inflammatory, and adolapin, 
another component, may play a role in analgesia by inhibition 
of cyclooxygenase. Bee’s venom also can reduce the symptoms 
of EAE in rat.[55] In bee’s venom therapy, patients may be at risk 
of allergic reactions. Nine patients with MS were treated with 
bee’s venom; no serious allergic reactions were seen. However, 
four patients showed some neurological symptoms that need to 
be studied further.[56]
Although new information about the efficacy of the venom 
therapy in the treatment of MS has been obtained, further clinical 
trials studies are needed.
Snake venom: Snake venom contains various compounds 
such as polypeptides, protein, and phospholipase. Venom of the 
Malayan pit vipers (Calloselasma rhodostoma), called Ancord, 
has an anticoagulant polypeptide. It also can delay inflammatory 
demyelination in animal models.
In inflammatory conditions, fibrin is deposited. Since the 
brain is permeable to protein in MS, deposition of fibrins leads 
to damage to axons and inflammatory demyelination. Therefore, 
fibrin exhaustion by the venom of snakes can inhibit inflamma‑
tory reaction.
Overall, there is no clinical trial proving the efficacy of snake 
venom therapy and studies are usually limited to experimental 
models.[54]
Sea anemone venom: Stichodactyla helianthus is a sea 
anemone which can produce peptide and protein as venom. In 
EAE models, voltage-gated potassium channels (Kv channels) are 
expressed. Venom of S. helianthus can block these channels. In 
addition, by blocking of Kv channels (especially Kv1.3), produc‑
tion of cytokine and proliferation of T-cell are reduced. Therefore, 
venom of sea anemone may play a role as an immunosuppressive 
agent and may be useful in MS.[56]
Alternative medical system
The six most used CAM therapies in MS include reflexol‑
ogy, massage, yoga, relaxation, meditation, aromatherapy, and 
acupuncture.[57]
Homeopathy
Homeopathy is a treatment system whose basic principle is “let 
like be treated by like.” This means that an individual who has an 
illness or a condition could be treated with a medicine that produces 
similar symptoms when a healthy individual uses it. Homeopathic 
medicines are given in a highly dilute form, so they are nontoxic. 
The system uses a very wide range of natural substances.[58]
Some kinds of homeopathic treatment are used frequently in 
MS symptoms. For example, for bladder symptoms and urinary 
retention, Causticum could be used. Bowel dysfunction, mainly 
constipation, may be treated by Opium, Alumina, Nux vomica, 
and sulphurarte. Daily use of phosphorus has been reported to be 
helpful for optic neuritis; combination with Hypericum makes it 
more effective. Gelsemium for double vision, Cuprum metalicum, 
Cuprum arsenicum, Nux vomica (馬錢子Mǎ Qián Zǐ), and Ignatia 
for cramp and spasm, and Secale for sensory symptoms have been 
reported to be effective in MS patients.[58]
Aromatherapy
Aromatherapy is the use of essential oil to improve health and 
well-being. In pain management, it has been commonly used. Aro‑
matherapy in MS patients could be effective for some symptomatic 
relief, such as helping in sleep, relaxation, mobility of joints and 
muscle, and improvement in the feeling of well-being.[59]
Acupuncture
Acupuncture (針灸Zhēn Jiǔ) is a frequently used method 
in neurological conditions such as spasticity, stroke, and fibro‑
myalgia. Studies show that acupuncture could be helpful for 
treating MS associated with fatigue. Acupuncture could release 
some neurohormones and opioids that affect the disease process 
and these substances could also slow down or even reverse the 
progression of MS.[60]
Chinese scalp puncture: Chinese scalp puncture is a combina‑
tion of Chinese needling method and Western medical knowledge 
of the cerebral cortex, and has been shown to be a very effective 
technique for treating MS and other CNS disorders. In this tech‑
nique, different areas in the brain, such as motor area, sensory area, 
foot motor and sensory area, balance area, hearing and dizziness 
area, and tremor area, are stimulated in MS patients. After treat‑
ment, patients can stand and walk without any problem. Patients 
have more energy, and their urinary problem and dizziness are 
solved. This technique not only relives symptoms but also in‑
creases the quality of life and slows or reverses the progression 
of physical disability. It also reduces the number of relapses and 
helps patients to remain in remission.[61]
Neural therapy: Neural therapy is a modified form of acupunc‑
ture that was investigated by Gibson for amelioration of symptoms 
of MS. This treatment is cheap and effective for MS and is very 
useful for patients with the ambulatory problems. It is suggested 
that this treatment restores the conduction capacity in intact demy‑
elinated axons. However, this treatment is almost new.[51]
Mind–body interventions
Mind–body interventions include meditation such as yoga 
and prayer.[14,15]
Yoga
Yoga mainly improves the general well‑being, including im‑
provement of mobility, muscle strength, and balance.[57] It is an 
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ancient Indian mind–body technique that focuses on meditation, 
mind fullness, breathing, and activity or posture. Yoga exercises 
can improve the muscle tone and reduce fatigue and spasticity. In 
a study on MS patients who attended weekly Iyengas classes – the 
most common type of yoga – for 9 months, significant improve‑
ment in fatigue was observed compared with the control group.[62]
Yoga intervention significantly improves fatigue, mobility, 
activity, and mental function.[63,64] Some forms of yoga, such as 
Bikram yoga which is done in hot temperature, are contraindicated 
in neurological disorder.[64]
Spirituality
Some studies explore spiritual well‑being in some neurologi‑
cal disorders such as MS. Patients aim to achieve spiritual selves 
through meditation and praying.[65,66] In a research conducted 
in Switzerland on 150 patients with MS during 8 weeks, it was 
observed that meditation can reduce the symptoms of MS, such 
as fatigue, anxiety, and depression, and can improve the quality 
of life.
Manipulative and body‑based methods
Manipulative and body‑based methods include massage, 
reflexology, and chiropractic medicine.[14,15]
Chiropractic
Many of the musculoskeletal symptoms associated with MS 
could be managed with physical therapies. Chiropractic is one of 
these therapies. It has shown efficacy in the treatment of chronic 
spinal pain, so it could be used for treatment of pain in MS pa‑
tients. Although chiropractic could be one of the choices for pain 
management, more studies are needed to show its efficacy in MS 
patients.[67,68]
Massage
A clinical trial shows that massage could be helpful in MS 
patients. Patients who had massage showed lower anxiety and 
lesser depressed mood.[51] The main benefits of using massage 
for MS patients include reduced pain, reduced spasms, improved 
circulation, increased joint and limb mobility, and improved 
general well-being.[57]
Tai Chi is an ancient Chinese traditional exercise that is a 
mixture of mind–body therapy and exercise in the form of slow 
rhythmic movements. It was originally meant for self-defense, but 
is used today to improve health, especially position, energy, and 
balance. In a study on MS patients, depression, spasticity, walking, 
and bladder dysfunction were found to improve.[69]
Ai chi is a combination of Tai chi and Qigong shiatsu tech‑
niques and is practiced by standing in deep water and deep breath‑
ing, with slow movements of the arms and legs. It is successfully 
used in pain management, MS, chronic obstructive pulmonary 
disease (COPD), diabetes, and arthritis. In a study on 73 patients 
with MS during 20 weeks, Ai chi was found to significantly reduce 
pain, spasticity, and fatigue.
Reflexology
Reflexology, also known as zone therapy, is done by ap‑
plying pressure with the thumb on specific points of the feet 
related to the internal body organs and glands. Reflexology 
could improve paresthesia, urinary symptoms, muscle strength, 
and spasticity.[51] It has been reported to be useful in reducing 
pain, stopping spasms, reducing bladder and bowel problems, 
and improving walking and the quality of life.[57] In a study on 
71 patients with MS, the symptoms of lack of sensation, muscle 
weakness, and cramps improved after they received 11 weeks 
of reflexology.[70]
Aquatic exercise
Aquatic exercise includes pool therapy, hydrotherapy, and 
balneotherapy which are used routinely for management of pain 
in patients with neuralgic pain. Warm water also increases the 
blood flow, which causes muscle relaxation.
Energy therapies
Energy therapy includes magnetic field therapy and therapeutic 
touch.[14,15]
Magnetic field induces electrical field and subsequently stimu‑
lates tissue and neuron. One study shows that repetitive stimulation 
has an antispastic effect on MS.[53] The mechanism is still unclear.
Other CAM therapies
Hyperbaric oxygen therapy is breathing oxygen at a higher 
level than the atmospheric pressure in a chamber for 20‑90 min 
each session for 4 weeks. The UK Federation of MS therapy sug‑
gested it as a useful, cost-effective method with few side effects. 
However, some studies showed no significant improvement.[19,71,72]
Art and dance therapy could be effective in the emotional state 
of MS patients and could improve their well-being.
MS symptoms often worsen in heat and warm environment. 
Cooling therapy is a method used to reduce body temperature. 
Cold bath or shower reduces fatigue.[19]
Toxin removal therapy
Toxic metals can cause neurodegenerative disease. Chela‑
tion therapy is a method in which toxic metals are removed 
from the body with chelators such as ethylenediamine tetraacetic 
acid (EDTA), vitamins, and minerals by excreting them in urine. 
A study on patients with MS showed that the level of toxic metal 
in urine reduces after chelation therapies.[19,73] Furthermore, che‑
lation therapy can reduce lipid peroxidation and oxidative DNA 
damage.[69]
Mercury, silver, copper, lead, and zinc are used as amalgam 
for filing of teeth. Mercury vapor can be produced in the mouth 
while chewing foods or drinking warm liquids. Removing dental 
fillings can be beneficial.[19,74,75]
Hormone therapy
Higher prevalence of MS in women and late onset in men 
show that the level of testosterone has a predictive effect on MS. 
Studies on animal models show that treatment with a high dose 
of testosterone in male and female mice is effective. Supplement 
therapy with testosterone in men could be considered as a choice, 
but high dose of testosterone in women has several adverse effects. 
Pregnancy and high dose of estradiol have a protective effect. 
Estradiol reduced severity of disease in EAE animal modeles. In 
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a clinical trial, oral treatment with estradiol was found to reduce 
inflammatory lesions in the brain.[1,76,77]
CONCLUSION
CAM has different definitions and is considered conventional 
or unconventional in different countries. It is not routinely taught 
in medical universities. Patients and health care professionals have 
a problem finding information regarding different kinds of CAM 
and usefulness of each. In addition, MS patients experience many 
problems after receiving conventional therapies. Discussing the 
available CAMs with their holistic nature may establish stronger 
patient–physician relationship leading to improved health and 
satisfaction. In addition, CAM helps patients as a friendly pal‑
liative care with low adverse effects by improving the quality of 
life. Anyway, long-term large-scale studies are needed to show 
the effectiveness of each CAM therapy.
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